Solutia to Supply Solar Thermal Power Plant in Spain With Heat Transfer Fluid

Solutia Inc. (NYSE: SOA) announced today that it will be supplying Therminol(R) synthetic heat transfer fluid to a new 50 MW solar thermal power plant in Lebrija, Spain, which will start up in spring 2010. Iberese, a Spanish company dedicated to building and managing plants powered by cogeneration and renewable energy, selected Therminol VP-1 due to its ability to meet demanding requirements of high temperature systems and Therminol's more than 20 years of experience in solar projects. The plant, located south of Seville, is part of a plan backed by Spain's government to have 10 solar plants of 50 MW each operating by 2010.

"Therminol's agreement with Iberese is in line with our strategy to provide innovative, high-quality products to our global partners in the fast growing solar market," said Richard Altice, vice president of commercial services, Technical Specialties. Therminol last announced a large global supply agreement in August 2008 with Flagsol GmbH (a subsidiary of Solar Millennium AG) for a 150 MW hybrid power plant using both natural gas and solar power in Kuraymat, Egypt.

"European nations, particularly Spain, have expressed a strong commitment to promoting and achieving record breaking growth in the solar market, and Therminol is an ideal partner to serve this expansion," said Miguel Villagomez, global Therminol commercial team lead for solar projects.

Therminol heat transfer fluid is used in the trough-shaped mirror assemblies to absorb concentrated sunlight and heat up to about 400 degrees C. The heated Therminol is used to generate steam which drives the power generating turbines.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.